8-K: SCWorx Regains Nasdaq Listing, Trading to Resume

SCWorx Corp. announced that the Nasdaq Hearings Panel has granted its request for reconsideration, determining the company has regained compliance with listing requirements and approving continued listing on The Nasdaq Capital Market.

Summary

• SCWorx Corp. has successfully had its delisting decision overturned by the Nasdaq Hearings Panel.
• The company has demonstrated compliance with Nasdaq's minimum bid price and publicly held shares requirements.
• Trading on The Nasdaq Capital Market is expected to be reinstated following Nasdaq's scheduling.
• The company's common stock will continue to trade on the OTCQB Venture Market until Nasdaq reinstatement.
• Investors in a recent private placement have waived their right to terminate their purchase agreements based on the prior delisting decision.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a highly positive development, indicating the company has successfully navigated a critical listing challenge and regained compliance, paving the way for potential market liquidity.

Positives

• Regained compliance with Nasdaq's minimum bid price requirement.
• Regained compliance with Nasdaq's minimum publicly held shares requirement (549,092 shares as of September 17, 2026).
• Nasdaq Hearings Panel granted reconsideration and approved continued listing.
• Trading suspension on Nasdaq (since April 14, 2026) will be lifted.
• Private placement investors have waived termination rights related to the prior delisting decision.
• Closing bid price has been at or above $1.00 per share since August 4, 2026.

Negatives

• The company was previously subject to a delisting decision by the Nasdaq Hearings Panel.
• Trading was suspended on Nasdaq since April 14, 2026.
• The company is subject to a one-year Discretionary Panel Monitor.
• Failure to meet listing standards during the monitor period will result in immediate delisting without a cure period.

Risks

• Risk that Nasdaq delays or does not reinstate trading.
• Risk that the Nasdaq Listing and Hearing Review Council reviews and reverses the decision.
• Risk of failing to satisfy any Nasdaq continued listing standard during the one-year Panel Monitor period, leading to immediate delisting without a cure period.
• Risk that private placement investors exercise termination rights if trading does not resume on Nasdaq by October 31, 2026, which could require returning $938,000 and reduce publicly held shares below minimums.
• The company must provide monthly reports on shares outstanding, insider holdings, and public float.

Future Outlook

Trading on The Nasdaq Capital Market is expected to be reinstated on a date to be scheduled by Nasdaq. The company must adhere to specific conditions for continued listing, including monthly reporting and a one-year Panel Monitor period. Failure to meet listing standards during the monitor period could result in immediate delisting.

Management Comments

• "We are pleased that the Panel has recognized the steps the Company has taken to regain compliance with Nasdaq's listing requirements and look forward to the resumption of trading on Nasdaq."
• Statement by Tim Hannibal, CEO of SCWorx.

Industry Context

StockSavvy.ai notes that maintaining a Nasdaq listing is crucial for many small-cap companies to access capital, enhance visibility, and attract institutional investors. This successful appeal demonstrates the company's ability to address regulatory requirements, which is a positive signal to the market.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for increased liquidity and market confidence with Nasdaq trading reinstatement.
• Investors in Private Placement: Waived termination rights, securing their investment subject to certain conditions.
• Nasdaq: Oversight of company's continued compliance with listing rules.

Next Steps

• Submit Nasdaq's reinstatement form (submitted October 5, 2026).
• Await Nasdaq to schedule the date for trading reinstatement.
• Provide monthly reports on shares outstanding, insider holdings, and public float to Nasdaq through October 5, 2027.
• Comply with the conditions of the Discretionary Panel Monitor for one year ending October 2, 2027.

Key Dates

Recommendation

The successful appeal to regain Nasdaq listing is a significant positive, removing a major overhang. However, the company remains under strict monitoring for a year, and past compliance issues suggest caution. A 'hold' recommendation reflects the improved outlook balanced against ongoing risks and the need to see sustained operational and compliance performance.

Keywords

Nasdaq Listing, Delisting, Compliance, Reconsideration, Publicly Held Shares, Bid Price, Trading Reinstatement, Private Placement